Skip to main content
Mérieux Equity Partners
Link Header
Investor Access
English
French
Menu
Main navigation
About Us
Invested Investors
Venture Capital
Growth / Buyout
Key Figures
AMF Regulation
Our People
Our Portfolio
ESG
News
Meet Us
I'm searching for
Image
We’re on the move, you stay in the news
Our news
Category
- Any -
Venture Capital
Growth & Buyout
Acquisitions & Partnerships
Appointments
Awards
Financial Results
New Investment
News
Regulatory & Product Launch
2023-11-30
Mérieux Equity Partners acquires a majority stake in Labquality
2023-11-08
Amyl Therapeutics receives additional €5M funding to advance therapeutic platform
2023-10-19
Mablink Bioscience Enters an Agreement to be Acquired by Lilly
2023-10-02
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialization
2023-09-19
MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
2023-09-18
Broken String Biosciences Series A fundraising
2023-09-15
PhysioAssist announces successful acquisition by Inogen Inc.
2023-09-13
Mérieux Equity Partners Closes Mérieux Participations 4 (“MP4”) Above Target and Welcomes New Team Members for Growth Buy-Out investment team, ESG and Investor Relations.
2023-09-12
Biobest signs agreement with Aqua Capital and GIC to acquire Biotrop in Brazil
Pagination
Page 1
Next page
››